News Releases
Sep 14, 2023
Axcella Announces Reverse Stock Split Effective September 19, 2023
Aug 29, 2023
Axcella Granted Patent for Long COVID Fatigue Treatment
Aug 03, 2023
Axcella Reports Second Quarter Financial Results and Provides Business Update
May 04, 2023
Axcella Reports First Quarter Financial Results and Provides Business Update
Apr 17, 2023
Axcella Announces Two Oral Presentations on AXA1125 for Long COVID Fatigue at ECCMID 2023
Apr 14, 2023
Trial investigating potential treatment for fatigue relief in people with long COVID reports results
Mar 30, 2023
Axcella Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Feb 15, 2023
Axcella Announces FDA IND Clearance Supporting Regulatory Path to Registration of AXA1125 for Long COVID Fatigue
Feb 09, 2023
Axcella Therapeutics to Participate in the SVB Securities’ 2023 Global Biopharma Conference
Jan 23, 2023
Axcella Announces Regulatory Path to Registration of AXA1125 for Long COVID Fatigue